SUMMARY In 19 control subjects, 33 patients with essential hypertension and normal plasma renin activity (PRA) and 11 patients with low PRA, secretory rates of 18-hydroxy-1l-deoxy-corticosterone (18-OH DOC), l1-deoxycorticosterone (DOC) and corticosterone were measured. Patients with low PRA were significantly older and had higher arterial pressure and slightly lower plasma potassium levels than patients with normal PRA. Mean 18-OH DOC secretion rate was higher in patients with normal PRA (603 ± 112 SEM Ag/24 hr) than in control subjects (219 ± 19) and considerably higher (P < 0.001) in patients with low PRA (1800 ± 472 (table 1) . This effect could be ascribed to the relaxing influence of the hospital environment. Antihypertensive medication (including diuretics) was discontinued at least two weeks before the investigation. Plasma renin activity was determined by the method of Boucher et al.12 Every patient had at least two renin determinations, one recumbent with a normal sodium and potassium intake (135 mEq of sodium and 90 mEq of potassium daily) and one or more after stimulation by upright posture and low salt diet for at least three days. The distinction between low and normal PRA was established according to the following limits: 1) on dietary sodium 135-mEq/24 hr, recumbent or upright -undetectable or below 0.1 ng/ml/hr; 2) on dietary sodium 10 mEq/24 hr recumbent or upright -below 0.6 ng/ml/hr. Patients showing at least two PRA values under these limits were considered to have low PRA, while those with responses over this limit were attributed to the group with normal PRA. In addition, a furosemide-test"3 was performed in four patients in the low renin group. All of them showed PRA values below 0.6 ng/ml/hr 4 to 5 hours after 40-60 mg of furosemide. According to these criteria, 11 patients (25%) with EH had low
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Patients and Methods A total of 44 white patients with EH and 19 control subjects were studied on the fourth day of a diet containing 135 mEq of sodium and 90 mEq of potassium. All control subjects had blood pressure repeatedly below 140/90 mm Hg and none had a family history of high blood pressure or other cardiovascular disease. Mean age was 34.1 ± 3.23 (SEM) years with a range from 20 to 62 years. A complete physical examination and the usual blood and laboratory tests were within normal limits (table 1) .
The hypertensive patients underwent a complete clinical 406 hypertensive patients. Plasma aldosterone was significantly higher in the hypertensive population than in control subjects whereas no significant difference was observed between the low-and normalrenin groups. A significant (P < 0.01) mutual positive correlation was found between the secretion rates of 18-OH DOC, DOC and corticosterone in patients with low plasma renin activity. In contrast, there was no correlation between the secretion rates of the three mineralocorticoids in control subjects and patients with normal plasma renin activity. These data suggest a biosynthetic variation of the mineralocorticoid pathways in essential hypertension. (table 1) . This effect could be ascribed to the relaxing influence of the hospital environment. Antihypertensive medication (including diuretics) was discontinued at least two weeks before the investigation. Plasma renin activity was determined by the method of Boucher et al. 12 Every patient had at least two renin determinations, one recumbent with a normal sodium and potassium intake (135 mEq of sodium and 90 mEq of potassium daily) and one or more after stimulation by upright posture and low salt diet for at least three days. The distinction between low and normal PRA was established according to the following limits: 1) on dietary sodium 135-mEq/24 hr, recumbent or upright -undetectable or below 0.1 ng/ml/hr; 2) on dietary sodium 10 mEq/24 hr recumbent or upright -below 0.6 ng/ml/hr. Patients showing at least two PRA values under these limits were considered to have low PRA, while those with responses over this limit were attributed to the group with normal PRA. In addition, a furosemide-test"3 was performed in four patients in the low renin group. All of them showed PRA values below 0.6 ng/ml/hr 4 to 5 hours after 40-60 mg of furosemide. According to these criteria, 11 patients (25%) with EH had low 2.4tt (10) (ng/ml) * = P < 0.05, ** = P < 0.01 vs patients with normal PRA. t = P < 0.05, tt = P < 0.01 vs control subjects. tSodium intake/24 hr. ¶Number of determinations in parentheses. Abbreviations: R = recumbent; U = upright; 1) = on day of admission; 2) = mean of 8-12 measurements during recumbency on the fourth day of hospitalization.
PRA and 33 had normal PRA. The main clinical and laboratory data for both groups are presented in table 1. Blood for aldosterone determination was drawn after overnight recumbency between 8 and 9 a.m. on the fourth day of the normal dietary salt intake. Aldosterone plasma concentration was determined by radioimmunoassay. 14 DOC and corticosterone secretion rates were simultaneously measured by a double isotopic derivative assay16 at random, whenever duration of hospitalization permitted.
In four patients with low PRA, DOC secretion rate was calculated from the determined DOC plasma level and the individual metabolic clearance rate for DOC ( 
Results
Patients with low PRA were older, presented with higher systolic and diastolic arterial pressure and slightly lower plasma potassium levels than patients with normal PRA (table 1). Plasma aldosterone was somewhat higher (P < 0.05) in patients with normal PRA and even higher (P < 0.01) in the low-renin group than in control subjects. No significant difference was found between hypertensives with normal and low PRA.
The mean DOC and corticosterone secretion rates were similar in control subjects and hypertensive patients (table  2) . There was also no difference between the normal-and the low-renin groups. In control subjects the 18-OH DOC secretion rates varied within a narrow range (73-267) whereas a wide scatter of values was observed in hypertensive patients. They were, however, significantly higher in the low-renin group when compared to control subjects (P < 0.001) and patients with normal PRA (P < 0.01). In the latter group 18-OH DOC secretion rates were above the normal range (mean ± 2 SD) in 16 of 33 patients and in 9 of 11 patients 27 However, it must be kept in mind that the mineralo- corticoid potency of 18-OH DOC is several times lower than that of aldosterone. The activity of 18-OH DOC on sodium transport across the membrane of the toad bladder has been estimated at about 1/40 of that of aldosterone9' 2 whereas the sodium retaining activity in the rat bioassay seems to be nearly equal to that of DOC. 29 Gotshall and Davis have reported30 that 18-OH DOC had 22% of mineralocorticoid activity of deoxycorticosterone acetate in the dog. Nonetheless, Oliver et al. have shown in the rat2" and more recently in the dog3' that the mineralocorticoid effect of 18-OH DOC does not parallel its action on the blood pressure which is more pronounced than the sodium retaining and potassium excretory activity. Fan et al.32 observed in the sheep that a combined infusion of aldosterone, cortisol, corticosterone, DOC and 1 1-deoxycortisol caused no significant change in arterial pressure whereas with the addition of 18-OH DOC a small but significant increase occurred. This predominant action on arterial pressure could provide a possible explanation for the relative lack of mineralocorticoid effects in low PRA patients. Our findings of increased 18-OH DOC secretion rates in patients with EH, especially with low PRA, suggest a possible participation of 18-OH DOC in the pathogenesis of high blood pressure and/or the observed slightly lower plasma potassium levels in patients with low PRA. A causal relationship, however, cannot be established before the biological activity of 18-OH DOC in humans has been directly evaluated. The 18-OH DOC excess observed in Cushing's disease,9 in which renin suppression seems to be rather unusual,33 argues against a direct renin suppressive effect of this mineralocorticoid, at least under those conditions. . The major finding of our study was the positive mutual correlation between the secretory rates of the three main mineralocorticoids other than aldosterone in low-renin EH, in contrast to the lack of correlation in patients with normal PRA and in control subjects. This correlation exists despite elevations of 18-OH DOC secretion rates up to pathological values while DOC and corticosterone secretion rates remain within physiological limits. The implication is a close interdependence in the secretion of the three mineralocorticoids in EH with low PRA, i.e., a biosynthetic variation of the mineralocorticoid pathways in this instance. This interrelation is obviously absent in hypertensive patients with normal PRA and in control subjects.
Our results of an increased 18-OH DOC secretion rate in one-half of hypertensive patients with normal PRA are at variance with those of Melby et al.8 ' who found an increased excretion of 18-OH TH DOC in patients with suppressed PRA only and those of Ulick34 who found no increase at all in the secretion rate in a small group of lowrenin hypertensives. On the other hand, Williams et al. recently observed significantly higher plasma levels of 18-OH DOC in 18 patients with normal renin EH (11.6 ± 1.6 ng/100 ml) than in 18 control subjects (5.4 ± 0.7) on a dietary sodium intake of 200 mEq/24 hr.3" These discrepancies may in part be due to a different selection of patients and the definition of low PRA hypertension, but also to methodological differences. There is circumstantial evidence that urinary 18-OH TH DOC, as determined by Melby et al.,9 does not reflect the adrenal production of 18-OH DOC and leads therefore to its underestimation.39 In the present study the radiochemical homogeneity of the doubly labeled urinary metabolite of 18-OH DOC was established in twothirds of the determinations. The presence of any major impurity such as the "dimer" of 18-OH DOC3" in the tracer injected was also eliminated by frequent chromatographic verification of radiochemical purity and storage in dry benzene. A methodological error due to some degree of biological instability of tritium atoms in the tracer, which was randomly labeled by the procedure of Wilzbach,37 exchanged with methanol and chromatographically purified cannot, however, be ruled out. Any tritium loss would lower the specific activity of the urinary metabolite in respect to this isotope and the calculated secretion rate would be overestimated to that extent.
The establishment of the limits between normal and low PRA has been based in all previous studies on arbitrary chosen limits using spot determinations of PRA 
